Experiences in the treatment of cystic fibrosis in the USA
Di Sant'Agnese, P.A.
Il Fracastoro 63(3): 425-433
1970
ISSN/ISBN: 0015-9271 PMID: 5517019 Document Number: 20538
Document emailed within 1 workday
Related Documents
Denter, M.; Ramsay, M.; Jenkins, T. 1992: Cystic fibrosis. Part I. Frequency of the delta F508 mutation in South African families with cystic fibrosis South African Medical Journal 82(1): 7-10Tirouvanziam, R.; Desternes, M.; Saari, A.; Puchelle, E.; Péault, B.; Chinet, T. 1998: Bioelectric properties of human cystic fibrosis and non-cystic fibrosis fetal tracheal xenografts in SCID mice American Journal of Physiology 274(4): C875-C882
De Jongste, J.C.; Neijens, H.J.; Duiverman, E.J.; Horrevorts, A.M.; Sinaasappel, M.; Kerrebijn, K.F. 1986: The treatment of cystic fibrosis Nederlands Tijdschrift Voor Geneeskunde 130(7): 297-301
Hopkins, S. 1995: Advances in the treatment of cystic fibrosis Nursing Times 91(39): 40-41
Jedlicková, Z.; Vávrová, V.; Houstĕk, J.; Výmola, F. 1990: Antibiotic treatment of cystic fibrosis Acta Universitatis Carolinae. Medica 36(1-4): 42-43
Hamer, L.; Parker, H.W. 1996: Treatment of cystic fibrosis in adults American Family Physician 54(4): 1291-1297
Sardet, A.; Feigelson, J. 1990: Cystic fibrosis: home treatment La Revue du Praticien 40(17): 1571-1574
Catchpole, A. 1989: Cystic fibrosis: intravenous treatment at home Nursing Times 85(12): 40-42
Cohen, P.A. 1971: Psychosocial problems in treatment of cystic fibrosis Pediatrics 47(2): 472
Bush, A. 1996: Modern methods in the treatment of cystic fibrosis Pediatria Polska 71(6): 566-572
Gutkowski, P.; Dmeńska, H. 1996: Cystic fibrosis--prevention, diagnosis, treatment Pneumonologia i Alergologia Polska 64(7-8): 515-526
Cobos Barroso, N. 1993: Up-date on the antibiotic treatment of pulmonary infection in cystic fibrosis Anales Espanoles de Pediatria 39(Suppl 55): 195-199
Kattwinkel, J.; Agus, S.G.; Taussig, L.M.; Di Sant'Agnese, P.A.; Laster, L. 1972: The use of L-arginine and sodium bicarbonate in the treatment of malabsorption due to cystic fibrosis Pediatrics 50(1): 133-137
Friolet, B. 1974: Current position in the diagnosis and treatment of cystic fibrosis (mucoviscidosis) Therapeutische Umschau. Revue Therapeutique 31(8): 578-584
Eastman, S.J.; Scheule, R.K. 1999: Cationic lipid:pDNA complexes for the treatment of cystic fibrosis Current Opinion in Molecular Therapeutics 1(2): 186-196
Croft, P.R.; Racz, M.I.; Bloch, J.D.; Palmer, C.H. 2005: Autopsy confirmation of severe pulmonary interstitial fibrosis secondary to Munchausen syndrome presenting as cystic fibrosis Journal of Forensic Sciences 50(5): 1194-1198
Andersen, H.J.; Bjure, J.; Hjalmarson, O.; Kjellmer, I. 1976: Lung function tests in cystic fibrosis as a means of guiding treatment Lakartidningen 73(10): 859-862
Galabert, C.; Lengrand, D.; Montet, J.C.; Dimier, J.L.; Chazalette, J.P. 1991: Use of ursodeoxycholic acid in the treatment of hepato-biliary complications in cystic fibrosis Pathologie-Biologie 39(6): 625-628
Mercantini, P.; Virgilio, E.; lo Conte, A.; Grieco, M.; Ziparo, V. 2012: Cystic fibrosis and retroperitoneal cystic lymphangioma: a novel match American Surgeon 78(1): E6-E7
Koletzko, S.; Stringer, D.A.; Cleghorn, G.J.; Durie, P.R. 1989: Lavage treatment of distal intestinal obstruction syndrome in children with cystic fibrosis Pediatrics 83(5): 727-733